It looks as if the ambiguities within the key variables outweigh predictive values for AMD's critical ZEN-related outcome. Without knowing anything significant about ZEN's future performance, the trade-off of ASP vs volumes is elusive. Not knowing the introduction date further muddles the picture. Die size and yields are not clear, for die size is no long following the square of minimum feature size * transistor count * fudge factor guesstimate. So, manufacturing unit cost is fuzzy in addition to the volume vs ASP curve.The bottom line seems to point strongly at AMD share positions being more of a gamble than investment.
News 
Market Data 
Discover 
